Abstract Submission

(Abstract submission button at the bottom of this page)

Dear Colleagues,

The online portal is now open for submission of scientific abstracts to be considered for presentation at next year's annual congress in Siracusa, Italy. 
This year we shall again accept submissions in the following categories 1) clinical oncology, 2) basic science, 3) radiation oncology and imaging, 4) surgical oncology and 5) pathology.

Abstracts will be considered for both oral and poster presentation and we hope for a stimulating and diverse program. 

A panel of reviewers will evaluate and score your abstract and you will be informed if you have been successful in your submission.

An abstract is a concise piece of scientific writing and we feel that it is important for us to provide some guidelines on its format. It is therefore strongly recommended that you read the guidelines and instructions that we have available on our website: https://www.esvonc.com/Congress/abstract-submission.

Our reviewers, many experienced presenters, have also made the following helpful suggestions:

Good luck and we look forward to welcoming you to the beautiful island of Sicily in May 2020.

Important dates for the 2020 congress abstract submission :


Guidelines and instructions

Based on experiences of former congresses, the guidelines and instructions have been updated by the abstract review committee. 

Please find in here links to the pages with (you can also find them in top left column) :


Are you a Resident and 35 or younger?

You might be eligible to compete for the Wim Misdorp Resident Award.

Read all about it on this page.


Ready to submit? 

Whoops, too late!


You will be redirected to the external online abstract submission system. This system allows you to edit your submitted abstract(s) until the final deadline. You will have to make a login and you're set to submit. If you've submitted in former years over the same system, it should recognize you or you can ask for your password using the forgotten password button.